Cellular kinetic and phenotypic heterogeneity in and among Burkitt's and Burkitt-like lymphomas

Journal of Pathology

Volumn 182, Issue 2, 1997, Pages 145-150

  Spina, Donatella ^a   Leoncini, Lorenzo ^a   Megha, Tiziana ^a   Gallorini, Marcella ^a   Disanto, Andrea ^a   Tosi, Piero ^a   Abinya, Othieno ^b   Nyong'o, Aggrey ^b   Pileri, Stefano ^c   Kraft, Rainer ^d   Laissue, Jean A ^d   Cottier, Hans ^d  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apoptosis; bcl 2; bcl 6; Burkitt's lymphoma; c myc; Mitosis

Indexed keywords

MYC PROTEIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL KINETICS; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MALE; MITOSIS; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

ADOLESCENT; ADULT; BURKITT LYMPHOMA; CELL CYCLE; CHILD; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HERPESVIRUS 4, HUMAN; HIV; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PHENOTYPE; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030854031     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199706)182:2<145::AID-PATH819>3.0.CO;2-P     Document Type: Article

References (30)

1. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 1990; 55: 133-260.
2. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
3. Payne CM, Grogan TM, Cromey DW, Bjore CG Jr, Kerrigan DP. An ultrastructural morphometric and immunophenotypic evaluation of Burkitt's and Burkitt's-like lymphomas. Lab Invest 1987; 57: 200-218.
4. Yano T, van Krieken JHJM, Magrath IT, Longo DL, Jaffe ES, Raffeld M. Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 1992; 79: 1282-1290.
5. Klein U, Klein G, Ehlin-Henriksson B, Rajewsky K, Küppers R. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med 1995; 1: 495-505.
6. Niedobitek G, Agathanggelou A, Rowe M, et al. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 1995; 86: 659-665.
7. Carbone A, Gloghini A, Gaidano G, et al. AIDS-related Burkitt's lymphoma. Morphologic and immunophenotypic study of biopsy specimens. Am J Clin Pathol 1995; 103: 561-567.
8. Preudhomme C, Dervite I, Wattel E, et al. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol 1995; 13: 812-820.
9. Bhatia K, Fan S, Spangler G, et al. A mutant p21 cyclin-dependent kinase inhibitor from a Burkitt's lymphoma. Cancer Res 1995; 55: 1431-1435.
10. Finke J, Fritzen R, Ternes P, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes. Blood 1992; 80: 459-469.
11. Cutrona G, Ulivi M, Fais F, Roncella S, Ferrarini M. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J Exp Med 1995; 181: 699-711.
12. Cattoretti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalinfixed, paraffin-embedded tissue sections. J Pathol 1993; 171: 83-98.
13. Leoncini L, Del Vecchio MT, Kraft R, et al. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas - a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 1990; 137: 1047-1057.
14. Leoncini L, Del Vecchio MT, Spina D, et al. Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int J Cancer 1995; 61: 826-831.
15. Luzi P, Leoncini L, Funto I, et al. Epstein-Barr virus infection in sinonasal non-Hodgkin's lymphomas. Virchows Arch 1994; 425: 121-125.
16. Miura T, Sakuragi J-I, Kawamura M, et al. Establishment of a phylogenetic survey system for AIDS-related lentiviruses and demonstration of a new HIV-2 subgroup. AIDS 1990; 4: 1257-1261.
17. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993; 170: 1-8.
18. Leoncini L, Spina D, Close P, et al. Abortive mitoses and nuclear DNA fragmentation in CD30+ large cells of Hodgkin's disease. Leuk Lymphoma 1996; 22: 119-124.
19. Spina D, Leoncini L, Del Vecchio MT, et al. Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol 1995; 177: 335-341.
20. Brugal G. Interpretation of proliferation markers. In: Wied GL, Bartels PH, Rosenthal DL, Schenk U, eds. Compendium on the Computerized Cytology and Histology Laboratory, Tutorials of Cytology. Chicago: 1994; 234-240.
21. Sabattini E, Gerdes J, Gherlinzoni F, et al. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 1993; 169: 397-403.
22. Wagner HP, Cottier H, Cronkite EP. Variability of proliferative patterns in acute lymphoid leukemia of children. Blood 1972; 39: 176-186.
23. Burkitt DP. The discovery of Burkitt's lymphoma. Cancer 1983; 51: 1777-1786.
24. Chen W-G, Chen Y-Y, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am J Pathol 1996; 148: 17-23.
25. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516-1526.
26. Arvanitakis L, Yaseen N, Sharma S. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-β1-mediated growth inhibition in EBV-positive B cells. J Immunol 1995; 155: 1047-1056.
27. Rowe M, Rowe DT, Gregory CD, et al. Differences in B-cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO (Eur Mol Biol Organ) 1987; 6: 2743-2751.
28. Gregory CD, Milner AE. Regulation of cell survival in Burkitt lymphoma: implications from studies of apoptosis following cold-shock treatment. Int J Cancer 1994; 57: 419-426.
29. Onizuka T, Moriyama M, Yamochi T, et al. BCL-6 gene product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Bhod 1995; 86: 28-37.
30. Kawamata N, Miki T, Fukuda T, Hirosawa S, Aoki N. The organization of the BCL6 gene. Leukemia 1994; 8: 1327-1330.